Ranok Therapeutics
珃诺生物
Ranok Therapeutics
Biotech/Healthcare
Ranok Therapeutics was founded in the second half of 2018 by a team of US-trained PhDs with extensive industry experience. It focuses on developing a molecular chaperone-mediated protein degradation technology platform.
Latest round: Series B (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.